Actively Recruiting
Chinese Multicenter Cohort Study Evaluating Spontaneous Intracerebral Hemorrhage Outcomes and Biomarkers
Led by Xiangya Hospital of Central South University · Updated on 2026-09-22
12000
Participants Needed
1
Research Sites
521 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a large prospective observational study called the Chinese Multicenter Cohort Study of Intracerebral Hemorrhage CASA to understand spontaneous intracerebral hemorrhage, a serious type of stroke that causes high death rates and long-term disability. The study aims to enroll about 10,000 adults with imaging-confirmed intracerebral hemorrhage and 2,000 healthy adults across more than 30 hospitals in China. It seeks to characterize functional outcomes at 90 days using the modified Rankin Scale and to identify factors influencing recovery and survival over up to 10 years. Participants with intracerebral hemorrhage receive usual medical care decided by their doctors. They undergo detailed baseline assessments including medical history, lifestyle habits, neurological and vascular tests, laboratory work, and brain imaging obtained as part of routine care. Blood, urine, and other biospecimens are collected and stored for molecular analyses. Healthy controls undergo similar baseline assessments and biospecimen collection without treatment. Follow-up visits for those with hemorrhage occur at 3 months, 6 months, and then annually for up to 10 years. During follow-up, researchers evaluate functional status using the modified Rankin Scale, track recurrent hemorrhages, and record survival status through clinical visits, phone calls, family contacts, and health records. Data quality is maintained through standardized procedures and monitoring. The main outcome is the full range of functional disability at 90 days, with additional outcomes including long-term functional changes, mortality, recurrent bleeding, and biomarker associations. This comprehensive data collection supports development of predictive models for patient outcomes.
CONDITIONS
Brief Title
Chinese Multicenter Cohort Study of Intracerebral Hemorrhage
Research Team
L
Le Zhang, Professor, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here